Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.3Revenue $M0.5Net Margin (%)-4,023.6Z-Score-2.3
Enterprise Value $M3.5EPS $-1.0Operating Margin %-3,682.4F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-4,023.6Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %-10.7Quick Ratio6.5Cash flow > EarningsY
Price/Sales97.15-y EBITDA Growth Rate %-44.1Current Ratio6.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-36.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-56.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M17.2ROI % (ttm)-69.0Gross Margin Increase y-yN

Gurus Latest Trades with CLSN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CLSN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CLSN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tardugno Michael HCEO 2014-08-15Buy4,000$3.12-1.92 view
Tardugno Michael HCEO 2014-08-15Buy4,000$3.12-1.92 view
Martinez Alberto R JrDirector 2014-08-15Buy5,000$3.12-1.92 view
Fritz Frederick J.Director 2014-08-14Buy4,000$3.2-4.38 view
Martinez Alberto R JrDirector 2014-06-26Buy5,000$3.36-8.93 view
Fritz Frederick J.Director 2014-06-11Buy5,000$3.2-4.38 view
Martinez Alberto R JrDirector 2014-06-11Buy5,000$3.2-4.38 view
Tardugno Michael HCEO 2014-06-11Buy5,000$3.2-4.38 view
Fritz Frederick J.Director 2014-03-14Buy2,500$3.86-20.73 view
Tardugno Michael HPresident and CEO 2014-03-14Buy4,000$3.84-20.31 view

Press Releases about CLSN :

    Quarterly/Annual Reports about CLSN:

    News about CLSN:

    Articles On GuruFocus.com
    Dead Biotech Plays Surge To Life May 07 2013 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 6,000 Shares Nov 19 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares Aug 17 2009 
    Celsion Reports Second Quarter 2009 Financial Results and Business Update Aug 05 2009 
    Celsion to Hold Second Quarter 2009 Financial Results Jul 31 2009 
    Celsion Corp. (CLSN) CEO Michael H Tardugno buys 3,750 Shares Mar 18 2009 
    Celsion Corporation to Hold Conference Call to Discuss Its Announced Japan License Agreement for The Dec 16 2008 
    Celsion Corporation Announces Exclusive Japan License Agreement with Yakult Honsha for ThermoDox® Dec 15 2008 

    More From Other Websites
    INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Celsion Corp.... Sep 17 2014
    Celsion Announces Highlights from Three Presentations Given at the International Liver Cancer... Sep 08 2014
    Celsion Reports Consolidated Duke University and Celsion's DIGNITY Study Clinical Data on... Sep 04 2014
    Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in... Sep 02 2014
    Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference Aug 28 2014
    CELSION CORP Files SEC form 8-K/A, Financial Statements and Exhibits Aug 25 2014
    CELSION CORP Financials Aug 19 2014
    CELSION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 07 2014
    Celsion Corporation Reports Second Quarter 2014 Financial Results Aug 07 2014
    Q2 2014 Celsion Corp Earnings Release - Before Market Open Aug 07 2014
    Celsion Corporation to Hold Second Quarter 2014 Financial Results Jul 31 2014
    Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver... Jul 28 2014
    Celsion (CLSN) in Focus: Stock Adds 5.3% in Session Jul 25 2014
    Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer Jul 24 2014
    Celsion's EGEN Acquisition Brings Immunotherapy And RNA Therapeutics To Its Cancer Platform Jul 22 2014
    Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for... Jul 21 2014
    Celsion Corporation (NASDAQ: CLSN) to Ring The NASDAQ Stock Market Closing Bell Jul 15 2014
    Celsion Corporation Announces Commercialization of Reagent Products Jul 15 2014
    Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 Jul 14 2014
    CELSION CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK